Detection of Mycobacterium Tuberculosis Resistance to Pyrazinamide Antibiotic Using Polymerase Chain Reaction (PCR) Technique
DOI:
10.29303/jbt.v22i4.4224Published:
2022-11-19Downloads
Abstract
The tuberculosis treatment control program is constrained by the outbreak of TB that is resistant to anti-tuberculosis drugs (OAT), especially multidrug-resistant tuberculosis. Confirmation of tuberculosis drug resistance really needs to be done in each area considering that there are variations in phenotypes and genotypes in each region through laboratory tests such as molecular biology tests. Aim of study to determine the prevalence of Mycobacteriumtuberculosis resistance to pyrazinamide antibiotics by PCR technique. This research is a descriptive exploratory study which has been carried out in the molecular biology laboratory of West Nusa Tenggara Provincial Public Hospital. The sample in this study was positive TB sputum obtained from Patut Patuh Patju Hospital The Province of West Nusa Tenggara. The results showed that 5 of the samples were pyrazinamide resistant. Concluded that Resistance to pyrazinamide antibiotics was found from 10 samples, 5 of which had developed resistance to pyrazinamide antibiotics.
Keywords:
Mycobacterium tuberculosis;Pyrazinamide resistance; PCRReferences
Campbell, P. J., Morlock, G. P., Sikes, R. D., Dalton, T. L., Metchock, B., Starks, A. M., Hooks, D. P., Cowan, L. S., Plikaytis, B. B., … & Posey, J. E. (2011). Molecular detection of mutations associated with first- and second-line drug resistance compared with conventional drug susceptibility testing of Mycobacterium tuberculosis. Antimicrobial Agents and Chemotherapy, 55(5), 2032–2041. https://doi.org/10.1128/AAC.01550-10
Gillespie, S. H. (2002). Evolution of drug resistance in Mycobacterium tuberculosis: Clinical and molecular perspective. Antimicrobial Agents and Chemotherapy, 46(2), 267–274. https://doi.org/10.1128/AAC.46.2.267-274.2002
Irianti, Kuswandi, Yasin, N, F., & Kusumaningtiyas, R, A. (2012). Mengenal Anti-Tuberculosis. In Current Bioactive Compounds (Vol. 2, Issue 1). https://doi.org/10.2174/1573407210602010105
Jiwintarum, Y., Diarti, M. W., & Dramawan, A. (2014). RESISTENSI PRIMER MYCOBACTERIUM TUBERCULOSIS DENGAN TARGET Gen rpoB. Jurnal Kesehatan Prima, 8(1), 1224–1231.
Kemenkes RI. (2010). Kementerian Kesehatan Republik Indonesia. Profil Kesehatan Indonesia. In Profil Kesehatan Indonesia 2010.
Kurniawan, E., Diarti, W., Pristianingrum, S. (2015). Analisis Molekuler Mdr Tb Dengan Teknik Sekuensing Dari Sampel Dahak Suspek Tb Di Nusa Tenggara Barat. Jurnal Kesehatan Prima, 9(1), 1436–1443.
Muhammad, M., & Fadli, F. (2019). Analisis Faktor Penyebab Multi-Drug Resistance (Mdr) Pada Penderita Tuberkulosis. Jurnal Publikasi Kesehatan Masyarakat Indonesia, 6(2), 62–67. https://doi.org/10.20527/jpkmi.v6i2.7454
Palomino, J. C., & Martin, A. (2014). Drug resistance mechanisms in Mycobacterium tuberculosis. Antibiotics, 3(3), 317–340. https://doi.org/10.3390/antibiotics3030317
Pym, A. S., Brodin, P., Brosch, R., Huerre, M., & Steward, T. C. (2002). Loss of RD1 Contributed to the attenuation of the live tuberculosis vaccine Mycobacterium bovis BCG and Mycobacterium microti. Molecular Microbiology, 46(3), 709–717.
Santos, L. C. (2012). Review: The Molecular Basis of Resistance in <i>Mycobaterium tuberculosis</i> Open Journal of Medical Microbiology, 02(01), 24–36. https://doi.org/10.4236/ojmm.2012.21004
Thakur, M. (2001). Global tuberculosis control report. The National Medical Journal of India, 14(3), 189–190.
Wicaksana, A. (2016). Https://Medium.Com/. https://medium.com/@arifwicaksanaa/pengertian-use-case-a7e576e1b6bf
License
Copyright (c) 2022 Edy Kurniawan, Idham Halid
This work is licensed under a Creative Commons Attribution 4.0 International License.
Jurnal Biologi Tropis is licensed under a Creative Commons Attribution 4.0 International License.
The copyright of the received article shall be assigned to the author as the owner of the paper. The intended copyright includes the right to publish the article in various forms (including reprints). The journal maintains the publishing rights to the published articles.
Authors are permitted to disseminate published articles by sharing the link/DOI of the article at the journal. Authors are allowed to use their articles for any legal purposes deemed necessary without written permission from the journal with an acknowledgment of initial publication to this journal.
